Congress to Probe FDA Handling of Ranbaxy
FDA Handling of Ranbaxy. Members of Congress are getting ready to investigate the scandal surrounding generic drug maker Ranbaxy. The House Energy and Commerce Committee has scheduled a hearing [...]